Диссертация (1139535), страница 50
Текст из файла (страница 50)
2006; 208: 535-42.52.Bateman BT, Schumacher HC, Bushnell CD, Pile-Spellman J, Simpson LL,Sacco RL, Berman MF. Intracerebral hemorrhage in pregnancy. Frequency, riskfactors and outcome. Neurology 2006; 67: 424–429.53.Beasley KM, Lovering AT, Gilbert JS. Decreased endothelial progenitorcells in preeclampsia and consequences for developmental programming.Hypertension.
2014 Jul;64(1):23-5.54.Bellamy L., Casas J. P., Hingorani A. D., Williams D. J. Pre-eclampsia andrisk of cardiovascular disease and cancer in later life: systematic review and metaanalysis. British Medical Journal. 2007, vol. 335; 7627: 974–977.55.Bilodeau JF. Review: maternal and placental antioxidant response topreeclampsia - impact on vasoactive eicosanoids. Placenta. 2014 Feb;35Suppl:S32-8.56.Blasco V, Leone M, Antonini F, Geissler A, Albanèse J, Martin C.Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch200/0.6 in brain-dead donor resuscitation on renal function after transplantation. BrJ Anaesth.
2008 Apr; 100(4): 504-8.31557.Böger RH, Diemert A, Schwedhelm E, Lüneburg N, Maas R, Hecher K. Therole of nitric oxide synthase inhibition by asymmetric dimethylarginine in thepathophysiology of preeclampsia. Gynecol Obstet Invest. 2010;69(1):1-13.58.Böhmer AE, Oses JP, Schmidt AP, Perón CS, Krebs CL, Oppitz PP, D'AvilaTT, Souza DO, Portela LV, Stefani MA. Neuron-specific enolase, S100B, and glialfibrillary acidic protein levels as outcome predictors in patients with severetraumatic brain injury. Neurosurgery. 2011 Jun;68(6):1624-30.59.Boldt J., Heesen M., Padberg W. et al. The influence of volume therapy andpentoxifylline infusion on circulating adhesion molecules in trauma patients.Anaesthesia. 1996; 51: 529-535.60.Breen EC. VEGF in biological control.
J Cell Biochem 2007; 102: 1358–1367.61.Brennan LJ, Morton JS, Davidge ST. Vascular dysfunction in preeclampsia.Microcirculation. 2014 Jan;21(1):4-14.62.Brewer J, Liu R, Lu Y, Scott J, Wallace K, Wallukat G, Moseley J, Herse F,Dechend R, Martin JN Jr, Lamarca B. Endothelin-1, oxidative stress, andendogenous angiotensin II: mechanisms of angiotensin II type I receptorautoantibody-enhanced renal and blood pressure response during pregnancy.Hypertension. 2013 Nov;62(5):886-92.63.Brewer J, Owens MY, Wallace K, Reeves AA, Morris R, Khan M, LaMarcaB, Martin JN Jr. Posterior reversible encephalopathy syndrome in 46 of 47 patientswith eclampsia.
Am J Obstet Gynecol. 2013 Jun;208(6): 468.e1-6.64.Brosens I, Pijnenborg R, Vercruysse L, Romero R. The "Great ObstetricalSyndromes" are associated with disorders of deep placentation. Am J ObstetGynecol. 2011; 204(3): 193-201.65.Brosens IА, Dixon HG, Robertson WB. Fetal growth retardation and thearteries of the placental bed.
BJOG. 1977; 84: 656-64.66.Brosens IА, Robertson WB, Dixon HG. The physiological response of thevessels of the placental bed to normal pregnancy. J Pathol Bacteriol. 1967; 93:569-79.31667.Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in thepathogenesis of preeclampsia. Obstet Gynecol Annu. 1972; 1: 177-91.68.Brunton PJ, Russell JA. Neuroendocrine control of maternal stress responsesand fetal programming by stress in pregnancy.
Prog Neuropsychopharmacol BiolPsychiatry. 2011; 35: 1178–1191.69.Brussé I1, Duvekot J, Jongerling J, Steegers E, De Koning I. Impairedmaternal cognitive functioning after pregnancies complicated by severe preeclampsia: a pilot case-control study. Acta Obstet Gynecol Scand. 2008;87(4):40812.70.Buckberry S, Bianco-Miotto T, Roberts CT. Imprinted and X-linked non-coding RNAs as potential regulators of human placental function.
Epigenetics.2014 Jan 1;9(1):81-9.71.Burger D., Touyz R. M. Cellular biomarkers of endothelial health:microparticles, endothelial progenitor cells, and circulating endothelial cells.Journal of the American Society of Hypertension. 2012; 6(2): 85–99.72.Burton GJ, Jauniaux E, Charnock-Jones DS. The influence of theintrauterine environment on human placental development.
Int JDevBiol.2010;54(2-3):303–312.73.Burton GJ, Woods AW, Jauniaux E, Kingdom JCP. Rheological andphysiological consequences of conversion of thematernal spiral arteries foruteroplacental blood flow during human pregnancy. Placenta. 2009;30(6):473–482.74.Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS. Placentalendoplasmic reticulum stress and oxidative stress in the pathophysiology ofunexplained intrauterine growth restriction and early onset preeclampsia.
Placenta2009;30 (suppl A): 43–48.75.Chaiworapongsa T, Espinoza J, Gotsch F, Kim YM, Kim GJ, Goncalves LF,Edwin S, Kusanovic JP, Erez O, Than NG, Hassan SS, Romero R. The maternalplasma soluble vascular endothelial growth factor receptor-1 concentration iselevated in SGA and the magnitude of the increase relates to Doppler317abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med2008; 21: 25–40.76.Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E,Dong Z, Tarca A, Gaurav B, Hassan S.
Maternal plasma concentrations ofangiogenic/anti-angiogenic factors are of prognostic value in patients presenting tothe obstetrical triage area with the suspicion of preeclampsia. J Matern FetalNeonatal Med. 2011 Oct;24(10):1187-207.77.ChaiworapongsaT,RomeroR,WhittenAE,KorzeniewskiChaemsaithong P, Hernandez-Andrade E, Yeo L, Hassan SS.SJ,The use ofangiogenic biomarkers in maternal blood to identify which SGA fetuses willrequire a preterm delivery and mothers who will develop pre-eclampsia. J MaternFetal Neonatal Med. 2015 Aug 14:1-15.78.Chazara O, Xiong S, Moffett A.
Maternal KIR and fetal HLA-C: a finebalance. J Leukoc Biol 2011; 90(4): 703-16.79.Chen DB, Wang W. Human placental microRNAs and preeclampsia. BiolReprod. 2013 May 23;88(5):130.80.Chen HH, Lin HC, Yeh JC, Chen CP. Renal biopsy in pregnanciescomplicated by undetermined renal disease. Acta Obstet Gynecol Scand2001;80:888–93.81.Chen X.K., Wen S.W., Smith G., Leader A., Sutandar M., Yang Q., WalkerM. Maternal age, paternal age and new-onset hypertension in late pregnancy.Hypertens Pregnancy 2006; 25: 217–227.82.Cheng SW, Chou HC, Tsou KI, Fang LJ, Tsao PN.
Delivery before 32weeks of gestation for maternal pre-eclampsia: neonatal outcome and 2-yeardevelopmental outcome. Early Hum Dev. 2004;76:39–46.83.Cindrova-Davies T, Sanders DA, Burton GJ, Charnock-Jones DS. SolubleFLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizingVEGF receptor-mediated signalling. Cardiovasc Res. 2011 Feb 15;89(3):671-9.84.Cipolla MJ, Sweet JA, Chan S-L.
Cerebral vascular adaptation to pregnancyand its role in the neurological complications of eclampsia. J Appl Physiol 2011;318110: 329–339.85.Cipolla MJ. Cerebrovascular function during pregnancy and eclampsia.Hypertension 2007; 50: 14–24.86.Cipolla MJ. The adaptation of the cerebral circulation to pregnancy:mechanisms and consequences.
J Cereb Blood Flow Metab. 2013 Apr;33(4):46578.87.Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA,Coomarasamy A, Zwinderman AH, Robson SC, Bindels PJ, Kleijnen J, Khan KS.Use of uterine artery Doppler ultrasonography to predict pre-eclampsia andintrauterine growth restriction: a systematic review and bivariable meta-analysis.CMAJ.
2008 Mar 11;178(6):701-11.88.Craici IM, Wagner SJ, Bailey KR, Fitz-Gibbon PD, Wood-Wentz CM,Turner ST, Hayman SR, White WM, Brost BC, Rose CH, Grande JP, Garovic VDPodocyturia predates proteinuria and clinical features of preeclampsia: longitudinalprospective study. Hypertension. 2013 Jun;61(6):1289-96.89.D’Mello C, Le T, Swain MG. Cerebral microglia recruit monocytes into thebrain in response to tumor necrosis factor alpha signaling during peripheral organinflammation. J Neurosci 2009; 29: 2089–2102.90.Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B,Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J. The predominance of Th17lymphocytes and decreased number and function of Treg cells in preeclampsia. JReprod Immunol (2012) 93(2):75–81.91.Day C, Hewins P, Hildebrand S, Sheikh L, Taylor G, Kilby M, et al.
Therole of renal biopsy in women with kidney disease identified in pregnancy.Nephrol Dial Transplant 2008;23:201–6.92.de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide incardiovascular disease. Lancet. 2003 Jul 26;362(9380):316-22.93.De Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, Anna R.Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. Acta ObstetGynecol Scand. 2008;87(8):837-842.31994.de Vries JI, van Pampus MG, Hague WM, Bezemer PD, Joosten JH. Low-molecular-weight heparin added to aspirin in the prevention of recurrent earlyonsetpre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT.
JThromb Haemost. 2012 Jan;10(1):64-72.95.Dekker G, Robillard PY, Roberts C. The etiology of preeclampsia: the roleof the father. J Reprod Immunol. 2011 May;89(2): 126-32.96.Dennis AT. Management of pre-eclampsia: issues for anaesthetists.Anaesthesia. 2012 Sep;67(9):1009-20.97.Di Battista AP, Buonora JE, Rhind SG, Hutchison MG, Baker AJ, RizoliSB, Diaz-Arrastia R, Mueller GP. Blood Biomarkers in Moderate-To-SevereTraumatic Brain Injury: Potential Utility of a Multi-Marker Approach inCharacterizing Outcome. Front Neurol. 2015 May 26;6:110.98.Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T.Absence of enhanced systemic inflammatory response at 18 weeks of gestation inwomen with subsequent pre-eclampsia.
British Journal of Obstetrics andGynaecology. 2002;109(7):759–764.99.Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesiumsulphate for women at risk of preterm birth for neuroprotection of the fetus.Cochrane Database Syst Rev. 2009 Jan 21; (1): CD004661.100. Drewlo S, Levytska K, Sobel M, Baczyk D, Lye SJ, Kingdom JC. Heparinpromotes soluble VEGF receptor expression in human placental villi to impairendothelial VEGF signaling. J Thromb Haemost. 2011 Dec; 9(12): 2486-97.101. Ducat A, Doridot L, Calicchio R, Méhats C, Vilotte JL, Castille J, BarbauxS, Couderc B, Jacques S, Letourneur F, Buffat C, Le Grand F, Laissue P, MirallesF, Vaiman D. Endothelial cell dysfunction and cardiac hypertrophy in the STOX1model of preeclampsia.
Sci Rep. 2016 Jan 13;6:19196.102. Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA,Lambert-Messerlian GM, Porter TF, Luthy DA, Comstock CH, Saade G,Eddleman K, Merkatz IR, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM,320D'Alton ME. Quad screen as a predictor of adverse pregnancy outcome. FASTERTrial Research Consortium.Obstet Gynecol. 2005;106:260–267.103. Dugoff L. Society for maternal–fetal medicine First- and second-trimestermaternal serum markers for aneuploidy and adverse obstetric outcomes.ObstetGynecol. 2010;115:1052–1061.104.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
